Real-world data use among small to midsize biopharma, medical device companies
By Merative MarketScan
As the evidence from real-world data (RWD) continues to meaningfully affect clinical trials and commercial pathways, organisations are more interested in engaging a variety of new datasets. But the trends surrounding that data uptake are rapidly changing, according to a new survey. Download the free report today for data-driven insights into RWD.